News ArticleGAIL to Attend Ashika Institutional Equities Investor Conference in Mumbai on November 5, 2026
Meetings with investor groups and one-on-one sessions scheduled from 11:00 AM, no unpublished price sensitive information to be disclosed
GAIL Ltd. has scheduled to participate in the Ashika Institutional Equities Investor Conference on November 5, 2026, in Mumbai. The event will include one-on-one and group meetings with investors, with no unpublished price sensitive information to be shared.
GAIL Ltd
General / Other
GAIL Ltd has announced its participation in the Ashika Institutional Equities Investor Conference on November 5, 2026, in Mumbai, where company officials will engage with institutional investors in one-on-one and group meetings starting at 11:00 AM.
The conference will be held in physical mode in Mumbai, providing GAIL an opportunity to meet with investor groups and institutions.
Company representatives have confirmed that no unpublished price sensitive information will be shared during these meetings.
This disclosure was made in line with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, to inform shareholders and the market about the scheduled investor engagement.
Copies of the announcement were also sent to Deutsche Bank AG and Beacon Trusteeship Limited as part of compliance.
Highlights
- GAIL officials to participate on November 5, 2026, in Mumbai
- Meetings commence at 11:00 AM featuring one-on-one and group investor discussions
- No unpublished price sensitive information will be shared
- Disclosure made as per regulatory requirements
Key Data Snapshot
What happened
- GAIL Ltd has scheduled participation in the Ashika Institutional Equities Investor Conference on November 5, 2026.
- The meetings will include both one-on-one and group sessions with investor groups.
- The conference will be held physically in Mumbai starting from 11:00 AM.
Regulatory and governance context
- The announcement complies with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- GAIL confirmed that no unpublished price sensitive information will be disclosed during the event.
- Copies of the disclosure were submitted to Deutsche Bank AG and Beacon Trusteeship Limited for record.
Highlights
- GAIL officials to participate on November 5, 2026, in Mumbai
- Meetings commence at 11:00 AM featuring one-on-one and group investor discussions
- No unpublished price sensitive information will be shared
- Disclosure made as per regulatory requirements
Disclosures
- Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
GAIL (India) Limited Reports ₹11,611.44 Crore Profit Before Tax for Q2 and H1 FY2026-27
GAIL (India) Limited announced its unaudited standalone financial results for the quarter and half year ended September 30, 2026, recording ₹11,611.44 crore profit before tax for the half year and total income of ₹86,116.52 crore.
Read Full Story
Max Healthcare Approves Q2 2026 Financial Results and Major Expansion Projects in Noida and Vaishali
Max Healthcare Institute Limited has approved its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The Board also approved capital expenditure plans totaling approximately ₹190 Crore to expand its hospitals in Noida and Vaishali, and revised the Gurugram hospital project cost and timeline.
Read Full Story
Max Healthcare Q2 FY27 Revenue Rises 20% to ₹3,219 Crore; PAT Increases 10% to ₹448 Crore
Max Healthcare Institute Limited reported a 20% year-on-year increase in gross revenue to ₹3,219 crore for the second quarter ended September 30, 2026, alongside a 10% rise in profit after tax to ₹448 crore. Operational bed capacity expanded by 16% year-on-year to 5,518 beds, supporting increased patient service volume.
Read Full Story
